Skip to content
Open access

Protective effects of quercetin in experimental ulcerative colitis: Potential involvement of ERK-MMP signaling.

Sep 2026 · Pakistan Journal of Pharmaceutical Sciences · Vol 40 1, pp. 285-292 · 0 citations · 30 references
Medicine

TL;DR

Quercetin showed protective effects in experimental UC models and these effects may be associated with modulation of the ERK-MMP signaling axis and further pathway-specific rescue experiments, pharmacokinetic studies and human-relevant models are required before this mechanism can be considered definitive or clinically translatable.

Abstract

Background

Ulcerative colitis is a relapsing inflammatory bowel disease driven by dysregulated immunity, epithelial barrier injury and microbial imbalance. Current therapies remain limited by relapse, adverse effects and incomplete response. Quercetin has anti-inflammatory and barrier-protective activities and ERK-MMP signaling may link inflammation to mucosal tissue damage.

Objectives

To evaluate whether the protective effects of quercetin in experimental ulcerative colitis (UC) are associated with modulation of ERK-MMP signaling, while avoiding causal overinterpretation beyond the animal and cellular evidence.

Methods

A dextran sulfate sodium (DSS)-induced mouse model and a lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage inflammatory model were used. Mice were allocated to the control, UC model and low-, medium- and high-dose quercetin groups. Disease activity index (DAI; unitless), colon length, histopathology, inflammatory cytokines and ERK/MMP-related molecules were evaluated by histological staining, ELISA, qRT-PCR and western blotting. In-vitro, quercetin was compared with the ERK phosphorylation inhibitor U0126 and an agonistic stimulus to explore pathway-related associations. The study was exploratory and did not include genetic rescue experiments or human validation.

Results

In DSS-treated mice, medium- and high-dose quercetin were associated with improved colon morphology, reduced DAI scores and partial restoration of colon length. Quercetin decreased pro-inflammatory cytokine expression and increased IL-10 expression. In both mouse colon tissues and LPS-stimulated RAW264.7 cells, quercetin was associated with reduced ERK1/2 activation and lower MMP-3 and MMP-9 expression, together with partial recovery of TIMP expression. These molecular changes were directionally consistent with the effects observed after ERK inhibition in-vitro.

Conclusion

Quercetin showed protective effects in experimental UC models and these effects may be associated with modulation of the ERK-MMP signaling axis. Further pathway-specific rescue experiments, pharmacokinetic studies and human-relevant models are required before this mechanism can be considered definitive or clinically translatable.

Read PDF

Similar papers

Open access Sep 2026

Calming the inflammatory storm: 4-methylcatechol ameliorates DSS-induced colitis by suppressing the NLRP3 inflammasome signaling pathway

4-MC treatment significantly ameliorated the disease manifestations of DSS-induced colitis, including weight loss, increased DAI, and colon shortening, and may protect against DSS-induced colitis by enhancing intestinal barrier function, attenuating inflammatory and oxidative stress responses, and suppressing NLRP3 inf...

Zi-Qiang Yang, Hong-Xiang Yuan, Wei-Qing Chen et al. · 0 citations
Conference Open access 2026

A Study on the Mechanism of Curcumin in Improving Ulcerative Colitis

The study found that curcumin improves physiological indicators such as survival rate and body weight in UC-affected mice and alleviates pathological damage to intestinal tissue, and the therapeutic effects were more pronounced in the high-concentration curcumin group and the treatment group receiving curcumin combined...

Jing-Zhe Chen · 0 citations
Open access Aug 2026

Integrated multi-omics, network pharmacology, and experimental validation reveal the protective mechanisms of curcumol against DSS-induced ulcerative colitis

Concurrent administration of CUR exerted protective effects in a DSS-induced mouse model of UC by reducing inflammation and mucosal barrier injury and partially normalizing gut microbial and fecal metabolic profiles.

Fu Shu, Kai-Qi Chen, Ying-Jie Song et al. · 0 citations
Open access Sep 2026

Kaempferol in inflammatory bowel disease: regulating intestinal epithelial-fibroblast crosstalk

Introduction Inflammatory bowel disease (IBD) has an intricate pathophysiology that greatly impacts patients’ quality of life. Wumei Wan, a traditional Chinese medicinal formulation, exhibits specific therapeutic effects on IBD. Kaempferol (KF), an active ingredient in Wumei Wan, may significantly contribute to IBD. Me...

Hai-Xia Qi, Gui-Qun Zhou, Yun-Fei Dong et al. · 0 citations
Open access Oct 2026

Evaluation of the Barrier-Protective Effects of Quercetin in an In Vitro Model of Inflammation-Induced Intestinal Dysfunction

Quercetin exhibited concentration-dependent cytoprotective effects against inflammation-associated cellular dysfunction, suggesting potential protective effects against oxidative and inflammatory damage.

{"name":"Nageswari Patnam","email":"patnamnageswari05@gmail.com","aff, {"name":"P. Devi Guna Sireesha","email":"patnamnageswari05@gma, {"name":"E Murali Nath","email":"patnamnageswari05@gmail.com" et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.